Last updated on July 2019

AGN-241751 in the Treatment of Major Depressive Disorder


Brief description of study

To evaluate the efficacy at 1 day post initial oral dose of AGN-241751 compared with placebo in participants with MDD

Clinical Study Identifier: NCT03586427

Find a site near you

Start Over

Health Initiatives Research PLLC

Fayetteville, AR United States
  Connect »

Synexus US - Cerritos

Cerritos, CA United States
  Connect »

Elite Clinical Trials, Inc.

Wildomar, CA United States
  Connect »

Synexus US - Atlanta

Atlanta, GA United States
  Connect »

Pillar Clinical Research

Lincolnwood, IL United States
  Connect »

Boston Clinical Trials

Boston, MA United States
  Connect »

Center for Emotional Fitness

Cherry Hill, NJ United States
  Connect »

Brooklyn Medical Institute

Brooklyn, NY United States
  Connect »

Neurobehavioral Research, Inc

Cedarhurst, NY United States
  Connect »

Synexus US - Queens

Jamaica, NY United States
  Connect »

Finger Lakes Clinical Research

Rochester, NY United States
  Connect »

IPS Research

Oklahoma City, OK United States
  Connect »

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.